The FDA has approved Novo Nordisk’s NovoSeven RT (recombinant human coagulation factor VIIa), another formulation of NovoSeven, that can be stored at room temperature (up to 81°F) for up to two years. The original NovoSeven formulation could be stored for 3 years at temperatures between 36–46°F.

NovoSeven RT shares the same indications as NovoSeven, which includes the treatment of bleeding and for surgical prophylaxis in Hemophilia A and B with inhibitors to Factors VIII and IX, in acquired hemophilia, and in congenital FVII deficiency.

For more information call (877) 668-6777 or visit www.novonordisk-us.com.